The results drive an early nephrology consultation as well as rational initial management, depending on the presence of intrinsic structural AKI (NGAL ≥ 150 ng/ml) or volume-responsive functional AKI (NGAL ≤ 50 ng/ml). The gene discussed is LCN2; the disease is acute kidney injury.